Cambridge Healthtech Institute主辦 第7回 國際會議/展示會 World Pharmaceutical Congress - 以有效率且安全之創藥為目標 - 2008年5月12日∼14日 - 美國 費城 Philadelphia Loews Hotel
申請
HTS之生物化學篩選法

第14回 HTS之生物化學篩選法

5月13日(二) ∼ 14日(三)

Title to Be Announced

Adam Hill, Ph.D., Director, Assay Development & HTS, Novartis

FUNCTIONAL ENZYMATIC ASSAYS

Discovery of Protease Inhibitor Probes by Target Class Profiling
Andrew Napper, Ph.D., Director, High-Throughput Screening, Penn Center for Molecular Discovery, University of Pennsylvania

Optimization of Enzymatic Assays for HTS: Sampling the Biochemical Space using a Parallel, Streamlined Approach
Daniele Carettoni, Ph.D., Head, Biochemistry, Axxam SpA

Title to Be Announced
Marshall Michener, Ph.D., Research Fellow, Inflammation Research, Pfizer Inc. (tentative)

Beyond Kinases: Interrogating the Purinome
Bob Lowery, Ph.D., President, CEO, Corporate, BellBrook Labs

BINDING ASSAYS

Drug Discovery in Academia: Two Examples of Novel Approaches to Biochemical Assays
Marcie Glicksman, Ph.D., Senior Director, Leads Discovery, Laboratory for Drug Discovery in Neurodegeneration, Brigham and Women’s Hospital

High-Throughput Screening for Inhibitors of p27Kip1 Proteolysis
Xuedong Liu, Ph.D., Associate Professor, Chemistry and Biochemistry, University of Colorado-Boulder

STRUCTURE-BASED ASSAYS

An Example of the Fragonomics Paradigm
Anthony Macherone, Ph.D., Senior Director, Analytical & Bioanalytical Services, ASDI Group of Companies


RECOMMENDED SHORT COURSE *Separate Registration Required

(DC1) 晚餐課程 生物化學篩選法用之工具及治療法的開發 (5月13日 9:00am - 12:00pm)

Tutor: Daniele Carettoni, Ph.D., Head, Biochemistry, Axxam SpA Xuedong Liu, Ph.D., Associate Professor, Department of Chemistry and Biochemistry, University of Colorado-Boulder

  • Functional Enzymatic Assays
  • Structure-based Drug Design
  • Binding Assays

Topics to be addressed for each:

  • The value of the expression host for recombinant protein expression
  • Protein engineering: truncations, ancillary domains, tags, etc.
  • Quality criteria for assay configuration aìnd screening
  • Assays and type of inhibitors (active-site, allosteric, exosite, etc.)
  • Types of assays used (surrogate substrates, enzymatic cascades, reactive probes, etc.)
  • What is the readout?
  • Benefits and limitations of each assay
  • What is the degree of throughput?
  • Homogeneous (addition-only steps) assays
  • How can assay and equipment be adapted for target when more complex assays are needed?

關於短期課程及晚餐課程


語言選擇:
English
Japanese
Korean

Corporate Sponsors:
Lead Sponsoring Publications:
Sponsoring Publications:
Web Partners: